Literature DB >> 28144971

Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up.

H Y Lee1, S A Walsh2, D Creamer2.   

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe adverse reactions to drugs that cause a life-threatening eruption of mucocutaneous blistering and epithelial sloughing. While the acute complications of SJS/TEN are well described, it is increasingly recognized that survivors may develop delayed sequelae, some of which can be associated with significant morbidity. Studies of long-term SJS/TEN outcomes mostly focus on mucocutaneous and ocular complications. However, other internal organs, such as the respiratory tract and gastrointestinal tract, can be affected. Psychological sequelae are also frequent following the trauma of widespread epidermal necrolysis. An appreciation of the 'chronic' phase of SJS/TEN is needed by clinicians caring for individuals who have survived the acute illness. This review aims to provide an update on the breadth and range of sequelae that can affect patients in the months and years following an acute episode of SJS/TEN.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2017        PMID: 28144971     DOI: 10.1111/bjd.15360

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

Review 1.  Biomarkers of adverse drug reactions.

Authors:  Daniel F Carr; Munir Pirmohamed
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-26

2.  Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.

Authors:  Eric P Borrelli; Erica Y Lee; Andrew M Descoteaux; Stephen J Kogut; Aisling R Caffrey
Journal:  Epilepsia       Date:  2018-11-05       Impact factor: 5.864

3.  Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Authors:  Swapna S Shanbhag; Ramy Rashad; James Chodosh; Hajirah N Saeed
Journal:  Am J Ophthalmol       Date:  2019-07-19       Impact factor: 5.258

4.  Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: A systematic integrative review.

Authors:  Pauline O'Reilly; Pauline Meskell; Barbara Whelan; Catriona Kennedy; Bart Ramsay; Alice Coffey; Donal G Fortune; Sarah Walsh; Saskia Ingen-Housz-Oro; Christopher B Bunker; Donna M Wilson; Isabelle Delaunois; Liz Dore; Siobhan Howard; Sheila Ryan
Journal:  PLoS One       Date:  2022-06-27       Impact factor: 3.752

5.  Toxic epidermal necrolysis after yellow fever vaccination.

Authors:  Thaís Bologna Flora; Célia Antônia Xavier de Moraes Alves; Fernanda de Mattos Pereira Barucci; Camila Bonati Mattos
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

6.  Anticancer Agent-Induced Life-Threatening Skin Toxicities: A Database Study of Spontaneous Reporting Data.

Authors:  Ryota Tanaka; Kan Yonemori; Akihiro Hirakawa; Fumie Kinoshita; Yumiko Kobayashi; Naoya Yamazaki; Manabu Fujimoto; Kenji Tamura; Yasuhiro Fujiwara
Journal:  Oncologist       Date:  2018-09-25

7.  Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; Leangelo Hall; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2020-03-19       Impact factor: 5.033

Review 8.  SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

Authors:  Katie D White; Riichiro Abe; Michael Ardern-Jones; Thomas Beachkofsky; Charles Bouchard; Bruce Carleton; James Chodosh; Ricardo Cibotti; Robert Davis; Joshua C Denny; Roni P Dodiuk-Gad; Elizabeth N Ergen; Jennifer L Goldman; James H Holmes; Shuen-Iu Hung; Mario E Lacouture; Rannakoe J Lehloenya; Simon Mallal; Teri A Manolio; Robert G Micheletti; Caroline M Mitchell; Maja Mockenhaupt; David A Ostrov; Rebecca Pavlos; Munir Pirmohamed; Elena Pope; Alec Redwood; Misha Rosenbach; Michael D Rosenblum; Jean-Claude Roujeau; Arturo P Saavedra; Hajirah N Saeed; Jeffery P Struewing; Hirohiko Sueki; Chonlaphat Sukasem; Cynthia Sung; Jason A Trubiano; Jessica Weintraub; Lisa M Wheatley; Kristina B Williams; Brandon Worley; Wen-Hung Chung; Neil H Shear; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb

9.  Ocular and Mucocutaneous Sequelae among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo.

Authors:  Bayaki Saka; Abla Séfako Akakpo; Julienne Noude Teclessou; Garba Mahamadou; Abas Mouhari-Toure; Kossi Dzidzinyo; Adam Nouhou Diori; Nidain Maneh; Sabin Prince-Agbodjan; Koussake Kombaté; Komi Balo; Kissem Tchangai-Walla; Palokinam Pitché
Journal:  Dermatol Res Pract       Date:  2019-01-30

Review 10.  Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Authors:  E C Kuijper; L E French; C P Tensen; M H Vermeer; J N Bouwes Bavinck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.